Behavioral intervention to reduce opioid overdose among high-risk persons with opioid use disorder: A pilot randomized controlled trial

被引:32
|
作者
Coffin, Phillip Oliver [1 ,2 ]
Santos, Glenn-Milo [1 ,2 ]
Matheson, Tim [1 ]
Behar, Emily [1 ,2 ]
Rowe, Chris [1 ]
Rubin, Talia [1 ]
Silvis, Janelle [1 ]
Vittinghoff, Eric [2 ]
机构
[1] San Francisco Dept Publ Hlth, San Francisco, CA 94102 USA
[2] Univ Calif San Francisco, San Francisco, CA 94143 USA
来源
PLOS ONE | 2017年 / 12卷 / 10期
关键词
INJECTION-DRUG USERS; NONFATAL HEROIN OVERDOSE; HIV PREVENTION INTERVENTION; NEW-YORK-CITY; NALOXONE DISTRIBUTION; CLINICAL-TRIAL; SAN-FRANCISCO; PROGRAM; DEATHS; VIRUS;
D O I
10.1371/journal.pone.0183354
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Objective The United States is amidst an opioid epidemic, including synthetic opioids that may result in rapid death, leaving minimal opportunity for bystander rescue. We pilot tested a behavioral intervention to reduce the occurrence of opioid overdose among opioid dependent persons at high-risk for subsequent overdose. Materials and methods We conducted a single-blinded randomized-controlled trial of a repeated dose motivational interviewing intervention (REBOOT) to reduce overdose versus treatment as usual, defined as information and referrals, over 16 months at the San Francisco Department of Public Health from 2014-2016. Participants were 18-65 years of age, had opioid use disorder by Structured Clinical Interview, active opioid use, opioid overdose within 5 years, and prior receipt of naloxone kits. The intervention was administered at months 0, 4, 8, and 12, preceded by the assessment which was also administered at month 16. Dual primary outcomes were any overdose event and number of events, collected by computer-assisted personal interview, as well as any fatal overdose events per vital records. Results A total of 78 persons were screened and 63 enrolled. Mean age was 43 years, 67% were born male, 65% White, 17% African-American, and 14% Latino. Ninety-two percent of visits and 93% of counseling sessions were completed. At baseline, 33.3% of participants had experienced an overdose in the past four months, with a similar mean number of overdoses in both arms (p = 0.95); 29% overdosed during follow-up. By intention-to-treat, participants assigned to REBOOT were less likely to experience any overdose (incidence rate ratio [IRR] 0.62 [95% CI 0.41-0.92, p = 0.019) and experienced fewer overdose events (IRR 0.46, 95% CI 0.24-0.90, p = 0.023), findings that were robust to sensitivity analyses. There were no differences between arms in days of opioid use, substance use treatment, or naloxone carriage. Conclusions REBOOT reduced the occurrence of any opioid overdose and the number of overdoses.
引用
收藏
页数:15
相关论文
共 50 条
  • [41] EFFECT OF SCALING UP MEDICATION FOR OPIOID USE DISORDER TO REDUCE OPIOID OVERDOSE DEATHS IN THE UNITED STATES
    Mueller, Peter
    Adee, Madeline
    Knudsen, Amy
    Wakeman, Sarah
    Chen, Qiushi
    Freedberg, Kenneth
    Barbosa, Carolina
    Zarkin, Gary A.
    Lietz, Anna P.
    Jalali, Mohammad S.
    Seguin, Claudia
    Pandharipande, Pari V.
    LaRochelle, Marc
    Chhatwal, Jagpreet
    MEDICAL DECISION MAKING, 2021, 41 (04) : E164 - E165
  • [42] IMPACT OF MEDICAL MARIJUANA LEGALIZATION ON OPIOID USE, CHRONIC OPIOID USE AND HIGH-RISK OPIOID USE
    Shah, A. B.
    Hayes, C. J.
    Lakkad, M.
    Martin, B. C.
    VALUE IN HEALTH, 2018, 21 : S247 - S247
  • [43] Impact of Medical Marijuana Legalization on Opioid Use, Chronic Opioid Use, and High-risk Opioid Use
    Anuj Shah
    Corey J. Hayes
    Mrinmayee Lakkad
    Bradley C. Martin
    Journal of General Internal Medicine, 2019, 34 : 1419 - 1426
  • [44] Impact of Medical Marijuana Legalization on Opioid Use, Chronic Opioid Use, and High-risk Opioid Use
    Shah, Anuj
    Hayes, Corey J.
    Lakkad, Mrinmayee
    Martin, Bradley C.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2019, 34 (08) : 1419 - 1426
  • [45] Incidence of Postoperative Opioid Overdose and New Diagnosis of Opioid Use Disorder Among US Veterans
    Siglin, Jonathan
    Sorkin, John D.
    Namiranian, Khodadad
    AMERICAN JOURNAL ON ADDICTIONS, 2020, 29 (04): : 295 - 304
  • [46] Socioeconomic correlates of incident and fatal opioid overdose among Swedish people with opioid use disorder
    Dahlman, Disa
    Ohlsson, Henrik
    Edwards, Alexis C.
    Sundquist, Jan
    Hakansson, Anders
    Sundquist, Kristina
    SUBSTANCE ABUSE TREATMENT PREVENTION AND POLICY, 2021, 16 (01)
  • [47] Socioeconomic correlates of incident and fatal opioid overdose among Swedish people with opioid use disorder
    Disa Dahlman
    Henrik Ohlsson
    Alexis C. Edwards
    Jan Sundquist
    Anders Håkansson
    Kristina Sundquist
    Substance Abuse Treatment, Prevention, and Policy, 16
  • [48] Anhedonia modulates benzodiazepine and opioid demand among persons in treatment for opioid use disorder
    Greenwald, Mark K. K.
    Moses, Tabitha E. H.
    Lundahl, Leslie H. H.
    Roehrs, Timothy A. A.
    FRONTIERS IN PSYCHIATRY, 2023, 14
  • [49] Overdose history is associated with postdetoxification treatment preference for persons with opioid use disorder
    Stein, Michael D.
    Flori, Jessica N.
    Risi, Megan M.
    Conti, Micah T.
    Anderson, Bradley J.
    Bailey, Genie L.
    SUBSTANCE ABUSE, 2017, 38 (04) : 389 - 393
  • [50] Association between trajectories of prescription opioid use and risk of opioid use disorder and overdose among US nonmetastatic breast cancer survivors
    Ching-Yuan Chang
    Bobby L. Jones
    Juan M. Hincapie-Castillo
    Haesuk Park
    Coy D. Heldermon
    Vakaramoko Diaby
    Debbie L. Wilson
    Wei-Hsuan Lo-Ciganic
    Breast Cancer Research and Treatment, 2024, 204 : 561 - 577